2016 World Vaccine Congress: Breakthroughs for Ebola, Zika & Cancer Vaccines
Experts from Merck, GSK, Pfizer, Sanofi Pasteur and more to debate breakthroughs for vaccines for Ebola, Zika and cancer (Source: Disabled World)
Source: Disabled World - March 7, 2016 Category: Disability Tags: Events Source Type: news

[Report] Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in protection against lethal disease, but the characteristics of the human antibody response to EBOV GP remain poorly understood. We isolated and characterized 349 GP-specific monoclonal antibodies (mAbs) from the peripheral B cells of a convalescent donor who survived the 2014 EBOV Zaire outbreak. Remarkably, 77% of the mAbs neutralize live EBOV, and several mAbs exhibit unprecedented potency. Structures of selected mAbs in complex with GP reveal a site of vulnerability located in the GP stalk region proximal to the viral membrane. Neutrali...
Source: ScienceNOW - March 4, 2016 Category: Science Authors: Zachary A. Bornholdt Source Type: news

Timely Access: The Waiting Game
Innovation in pharma is in itself a complex and drawn-out process – where inspiration and perspiration merge over years to produce a novel compound or molecule that will benefit human health. Yet while this process has been increasingly streamlined as science and technology progresses, drug approval processes remain a painstaking process that can significantly delay access to groundbreaking and effective therapies. Despite the central role of industry in healthcare delivery, outcomes and development, innovation in the form of lifesaving or life-prolonging medicines is now being scuppered by lengthy gaps between marke...
Source: EyeForPharma - February 25, 2016 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news

Ebola survivors have long-term health problems
Study reveals ongoing brain symptomsRelated items from OnMedicaWHO green lights use of experimental drugs to curb Ebola spreadScientists unlock Ebola’s deadly secret Experimental Ebola vaccine effective on needle stick doctor Ebola UK nurse readmitted for specialist treatmentWHO responded 'too slowly' to Ebola warnings (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 25, 2016 Category: UK Health Source Type: news

2 Experimental Ebola Vaccines Show Potential
Both produced high levels of antibodies to the deadly virus, researchers say (Source: WebMD Health)
Source: WebMD Health - February 24, 2016 Category: Consumer Health News Source Type: news

2 Experimental Ebola Vaccines Show Potential
Both produced high levels of antibodies to the deadly virus, researchers say (Source: U.S. News - Health)
Source: U.S. News - Health - February 24, 2016 Category: Consumer Health News Source Type: news

Two Experimental Ebola Vaccines Show Potential
WEDNESDAY, Feb. 24, 2016 -- Two experimental Ebola vaccines showed promise in a clinical trial, researchers report. The vaccines triggered an immune response and were well-tolerated among people in the phase 2 trial conducted in Liberia, one of the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 24, 2016 Category: Journals (General) Source Type: news

The Latest On Zika: The U.S. Investigates More Cases Of Sexual Transmission
The Zika virus, which is spread by the Aedes aegypti mosquito, is strongly suspected to be linked to a new wave of microcephaly cases in Brazil. Babies born with the birth defect have smaller heads and sometimes brains that aren't fully developed, which can result in life-long developmental problems.    Zika is currently spreading through Central and South America and the Caribbean, and with the high volume of news about the virus, it's tough to stay up-to-date. Check out our full coverage, or read our daily recaps. Here are four updates, opinions and developments to know about now:  ...
Source: Science - The Huffington Post - February 23, 2016 Category: Science Source Type: news

Experimental Ebola vaccines well tolerated, immunogenic in phase 2 study
(NIH/National Institute of Allergy and Infectious Diseases) Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized, placebo-controlled clinical trial called PREVAIL I. These findings were presented by one of the co-principal investigators, Fatorma Bolay, Ph.D., director of the Liberian Institute for Biomedical Research, this evening at the Conference on Retroviruses and Opportunistic Infections in Boston. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 23, 2016 Category: Infectious Diseases Source Type: news

Zika Was First Discovered in 1947. Why Is it Now a Threat?
Mostly innocuous and fairly unknown until a few weeks ago, the Zika virus is suddenly dominating the news. Under scrutiny is the virus's putative link with a congenital birth defect called microcephaly, which causes babies to be born with abnormally small heads and undeveloped brains. Two recent publications [1,2] have documented finding the genome of the Zika virus in the amniotic fluid and brains of fetuses affected by microcephaly from three different mothers. These numbers are still too small to constitute a proof, and in fact, alternative theories are already cropping up: an organization of Argentinean doctors has pu...
Source: Science - The Huffington Post - February 22, 2016 Category: Science Source Type: news

Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor
A new group of powerful antibodies to fight Ebola virus has been discovered by a team of scientists. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 19, 2016 Category: Science Source Type: news

Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor
(Scripps Research Institute) A research team that included scientists from The Scripps Research Institute has identified a new group of powerful antibodies to fight Ebola virus. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2016 Category: Global & Universal Source Type: news

Newly discovered Ebola-fighting antibodies could aid vaccine research
In the blood of a survivor of the recent Ebola outbreak, a team of researchers has discovered a number of antibodies that seem to successfully combat the deadly virus in mice. The findings, published in the journal Science, may help point scientists in the right direction for developing a vaccine... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - February 19, 2016 Category: Science Authors: Amina Khan Source Type: news

Blood From Ebola Survivor Yields Clues For New Vaccines And Antibody Drugs
A precious blood sample arrived at Laura Walker?s lab in Lebanon, New Hampshire one year ago. It wasn?t much--just 50 milliliters. But this tiny sample turned out to hold tremendous scientific value. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 18, 2016 Category: Pharmaceuticals Authors: Luke Timmerman Source Type: news

6 Things Every Traveler Should Know About The Zika Virus
If there's one thing we know about travelers, it's that they have a lot on their minds. And who can blame them? From terrorist attacks to travel warnings in popular vacation destinations across the globe, there's plenty to cause concern for the wanderlust crowd among us. Sadly, the Zika virus is merely the latest alarm bell for travelers. If you're wondering whether it's a smart idea to modify your plans in light of recent outbreaks, here's what you need to know. 1. What are the latest developments? The White House has requested $1.8 billion in emergency funding from Congress to combat the virus. A Reuters/lpsos poll relea...
Source: Healthy Living - The Huffington Post - February 18, 2016 Category: Consumer Health News Source Type: news

Liberia: Vaccines Versus Superbugs
[New Dawn] The outbreak of the Zika virus, like Ebola before it, has highlighted the risk that infectious diseases can pose to the health of entire countries - and the importance of vaccines to the fight against fast-moving epidemics. Indeed, efforts are already underway to find ways to inoculate people against both viruses. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 18, 2016 Category: African Health Source Type: news

European microbiology labs ‘well prepared’ for infectious disease threats
But licensing of labs and accreditation of tests need to be improved, says reportRelated items from OnMedicaDengue fever and West Nile virus threat to the UKCoronavirus ‘not yet reached pandemic potential’Better use of vaccines could help tackle antimicrobial resistance WHO responded 'too slowly' to Ebola warningsEuropean medicines regulator sets up Zika virus task force (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 16, 2016 Category: UK Health Source Type: news

New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola
(University of Plymouth) As the latest in a series of studies, researchers have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model. Demonstration of protection in the NHP model is regarded as a critical step before translation of Ebola virus vaccines into humans and other great apes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 15, 2016 Category: Infectious Diseases Source Type: news

Researchers present inner workings of Ebola vaccine trial
(University of Florida) An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 12, 2016 Category: Infectious Diseases Source Type: news

The Latest On Zika: Why The Pope Should Weigh In On Contraception
This week, while research groups formed coalitions to develop a Zika virus vaccine, scientists learned more about the disease after an autopsy report showed Zika virus in brain tissue of an aborted fetus. The fetus's mother had contracted Zika virus in Brazil during her first trimester.  The Zika virus, which is spread by the Aedes aegypti mosquito, is strongly suspected to be linked to a new wave of microcephaly cases in Brazil. Babies born with the birth defect have smaller heads and brains that aren't fully developed, which can result in life-long developmental problems.    With the high volume of ne...
Source: Healthy Living - The Huffington Post - February 12, 2016 Category: Consumer Health News Source Type: news

Real-time Ebola fusion system yields clues to stopping infection
The first real-time system has been developed to watch directly through the microscope as Ebola-like virus particles fuse with human cells to infect them. Their findings reveal key host cell and viral proteins that direct fusion and Ebola infection. Such knowledge is crucial for designing future drugs or vaccines to prevent this deadly disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 11, 2016 Category: Science Source Type: news

Real-time Ebola fusion system yields clues to stopping infection
(American Society for Microbiology) Researchers have developed the first real-time system to watch directly through the microscope as Ebola-like virus particles fuse with human cells to infect them. Their findings, published this week in mBio, an online open-access journal of the American Society for Microbiology, reveal key host cell and viral proteins that direct fusion and Ebola infection. Such knowledge is crucial for designing future drugs or vaccines to prevent this deadly disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 11, 2016 Category: Biology Source Type: news

January's top stories: Profectus Ebola trial, AstraZeneca-Incyte lung cancer drug
Profectus BioSciences began VesiculoVax-vectored vaccine trial, AstraZeneca and Incyte announced combination drug evaluation, SillaJen started Phase III trial for Pexa-Vec. Drugdevelopment-technology.com wraps-up the key headlines from January. (Source: Drug Development Technology)
Source: Drug Development Technology - February 5, 2016 Category: Pharmaceuticals Source Type: news

Already Struggling With Dengue, Hawaii Braces Itself For Zika
The mosquito-borne Zika virus could hit Hawaii especially hard if it arrives in the Aloha State, according to an expert from the Centers for Disease Control and Prevention. While a widespread outbreak of Zika in the Hawaiian islands remains unlikely at the moment, the state is at higher risk because of its tropical climate and large number of foreign travelers. And many experts are voicing serious concerns about the state's ability to handle such an event, should it occur. Hawaii is already battling its largest outbreak of dengue fever since the 1940s, a disease that is carried by the sam...
Source: Science - The Huffington Post - February 3, 2016 Category: Science Source Type: news

What the rise of Zika (and other viruses) might tell us about our planet
Follow me at @JohnRossMD Zika virus, a pathogen that was almost unknown a few months ago, is now rampant in Central and South America and the Caribbean. In Brazil, it has already infected about 1.5 million people and caused nearly 4,000 cases of microcephaly, a severe birth defect. It is almost certain to spread to every country in the Americas, except Canada and Chile, which lack the Aedes mosquitoes that spread Zika. Zika is not the only virus that has come from the tropics to menace the United States. Dengue, an unpleasant and potentially fatal viral infection, has broken out in Texas, Florida and Hawaii in the past 10 ...
Source: New Harvard Health Information - February 3, 2016 Category: Consumer Health News Authors: John Ross, MD, FIDSA Tags: Health Infectious diseases Prevention Safety Source Type: news

What Pregnant Women Should Know About Zika Virus
On Monday, the World Health Organization declared a "public health emergency of international concern" due to the cluster of birth defects potentially linked to Zika virus.   No one is probably more concerned about this connection than the world’s pregnant women, especially those who are living in an area where there is ongoing Zika virus transmission. While the virus’ symptoms (fever, headache, joint pain, conjunctivitis) are no cause for alarm and rarely require hospitalization, the disease is suspected of causing severe birth defects like microcephaly, when a baby is born with an abnormally sm...
Source: Science - The Huffington Post - February 2, 2016 Category: Science Source Type: news

What you need to know about Zika virus
Follow me at @JohnRossMD Last week, the government of El Salvador gave what might be the strangest public health advice of all time: don’t get pregnant for the next two years. Officials in Colombia, Ecuador, and Jamaica have also warned women to avoid pregnancy, although only for the next several months. The reason for these unusual recommendations? An outbreak of Zika virus, currently raging in 21 countries in the Americas and the Caribbean, as well as the U.S. Virgin Islands, the Commonwealth of Puerto Rico, Samoa, and Cape Verde. Until recently, Zika was an obscure virus, confined to equatorial Africa and Asia, an...
Source: New Harvard Health Information - February 1, 2016 Category: Consumer Health News Authors: John Ross, MD, FIDSA Tags: Children's Health Family Planning and Pregnancy Infectious diseases Prevention Safety Source Type: news

Why Are We Seeing an Explosion of New Viruses Like Zika?
Zika virus, Ebola, Middle East Respiratory Syndrome (MERS) coronavirus, Severe Acute Respiratory Syndrome (SARS) coronavirus, Nipah virus, Hendra virus, bird flu, swine flu -- these viruses have all grabbed international attention in recent years. In the past few decades the world has witnessed an alarming surge in emerging infectious diseases (EIDs). Since 1980, new pathogens have emerged in the human population at a rate of about three each year. Why are we seeing such a surge in new pathogens? One could argue that some of the pathogens may not be new at all; they could have circulated among humans for centuries and are...
Source: Science - The Huffington Post - February 1, 2016 Category: Science Source Type: news

What The Ebola Crisis Can Teach Us About Responding To The Zika Outbreak
Every week, The WorldPost asks an expert to shed light on a topic driving headlines around the world. Today, we speak with Georgetown University’s Daniel Lucey and Lawrence Gostin about the global response to the Zika virus. The World Health Organization was widely criticized for delays and mismanagement in its response to the Ebola crisis that ravaged three West African countries in 2014.  The Ebola virus has killed over 11,000 people, mostly in Liberia, Sierra Leone and Guinea, since 2013. Liberia and Guinea have recently been declared Ebola-free, although experts warn the virus can qu...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news

What The Ebola Crisis Can Teach Us About Responding To The Zika Outbreak
Every week, The WorldPost asks an expert to shed light on a topic driving headlines around the world. Today, we speak with Georgetown University’s Daniel Lucey and Lawrence Gostin about the global response to the Zika virus. The World Health Organization was widely criticized for delays and mismanagement in its response to the Ebola crisis that ravaged three West African countries in 2014.  The Ebola virus has killed over 11,000 people, mostly in Liberia, Sierra Leone and Guinea, since 2013. Liberia and Guinea have recently been declared Ebola-free, although experts warn the virus can qu...
Source: Healthy Living - The Huffington Post - January 30, 2016 Category: Consumer Health News Source Type: news

What The Ebola Crisis Can Teach Us About Responding To The Zika Outbreak
Every week, The WorldPost asks an expert to shed light on a topic driving headlines around the world. Today, we speak with Georgetown University’s Daniel Lucey and Lawrence Gostin about the global response to the Zika virus. The World Health Organization was widely criticized for delays and mismanagement in its response to the Ebola crisis that ravaged three West African countries in 2014.  The Ebola virus has killed over 11,000 people, mostly in Liberia, Sierra Leone and Guinea, since 2013. Liberia and Guinea have recently been declared Ebola-free, although experts warn the virus can qu...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news

Zika Virus Is At Least 50 Years Old. Here's Why You're Only Hearing About It Now.
As the Zika virus spreads, so has widespread alarm and confusion. The leader of the World Health Organization said Wednesday that it is "spreading explosively," estimating up to 4 million infections over the next year.   The Centers for Disease Control and Prevention has said that a U.S. outbreak of the mosquito-borne virus, which is spreading rapidly through mostly central and south America, is "likely," but the risk for local transmission is low. In Brazil, the virus has been linked to several thousand cases of microcephaly, a rare birth defect which causes shrinkage of the skull and br...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news

Zika Virus Is At Least 50 Years Old. Here's Why You're Only Hearing About It Now.
As the Zika virus spreads, so has widespread alarm and confusion. The leader of the World Health Organization said Wednesday that it is "spreading explosively," estimating up to 4 million infections over the next year.   The Centers for Disease Control and Prevention has said that a U.S. outbreak of the mosquito-borne virus, which is spreading rapidly through mostly central and south America, is "likely," but the risk for local transmission is low. In Brazil, the virus has been linked to several thousand cases of microcephaly, a rare birth defect which causes shrinkage of the skull and br...
Source: Healthy Living - The Huffington Post - January 30, 2016 Category: Consumer Health News Source Type: news

Zika Virus Is At Least 50 Years Old. Here's Why You're Only Hearing About It Now.
As the Zika virus spreads, so has widespread alarm and confusion. The leader of the World Health Organization said Wednesday that it is "spreading explosively," estimating up to 4 million infections over the next year.   The Centers for Disease Control and Prevention has said that a U.S. outbreak of the mosquito-borne virus, which is spreading rapidly through mostly central and south America, is "likely," but the risk for local transmission is low. In Brazil, the virus has been linked to several thousand cases of microcephaly, a rare birth defect which causes shrinkage of the skull and br...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news

U.S. Scientists Are Starting From Ground Zero With The Zika Vaccine
As the research community gears up to address Zika virus, one common question has been why, if we’ve known about Zika since 1947, are we only starting these efforts in 2016? As Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, admitted, the disease is uncharted territory. "We, prior to this time, have really not spent anything on Zika,” he said during a press conference Thursday. Currently, there is no cure and no vaccine for the disease, and diagnosing the disease takes up to two weeks in specialized labs.  To ramp up research on the Zika virus threat...
Source: Healthy Living - The Huffington Post - January 29, 2016 Category: Consumer Health News Source Type: news

A Mosquito Net Descends Across the Americas
We are a few weeks away from the 70th anniversary of Winston Churchill's famous speech in Fulton, Missouri, the one where he announced (with Churchillian timbre) that "from Stettin in the Baltic to Trieste in the Adriatic an iron curtain has descended across the Continent." He named the geopolitical fact that would dominate the globe for the next 40 years, the single factor that would focus, and often warp and distort, everyone's worldview for most of the rest of the 20th century. Sometime in the last 10 days, a mosquito net has descended across the Americas. It is unlikely to cause armed conflict between great p...
Source: Science - The Huffington Post - January 28, 2016 Category: Science Source Type: news

UK is 'vulnerable' to next epidemic
The UK is vulnerable to epidemics such as Ebola due to a gaping hole in the country's ability to manufacture vaccines, a group of MPs warns. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 25, 2016 Category: Consumer Health News Source Type: news

Marriott CEO: Stop Applauding People Who Boast About Not Sleeping
(function(){var src_url="https://spshared.5min.com/Scripts/PlayerSeed.js?playList=519438173&height=&width=100&sid=577&origin=undefined&videoGroupID=155847&relatedNumOfResults=100&responsive=true&ratio=wide&align=center&relatedMode=2&relatedBottomHeight=60&companionPos=&hasCompanion=false&autoStart=false&colorPallet=%23FFEB00&videoControlDisplayColor=%23191919&shuffle=0&isAP=1&pgType=cmsPlugin&pgTypeId=addToPost-top&onVideoDataLoaded=track5min.DL&onTimeUpdate=track5min.TC&onVideoDataLoaded=HPTrack.Vid.DL&onTimeUpdate=HPTrack...
Source: Healthy Living - The Huffington Post - January 23, 2016 Category: Consumer Health News Source Type: news

Antibodies from Ebola survivors may lead to better treatment
Stephen FellerNASHVILLE, Jan. 22 (UPI) -- Scientists identified antibodies in Ebola survivors they think may lead to better treatment or a vaccine for multiple forms of Ebola, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 22, 2016 Category: Consumer Health News Source Type: news

West Africa: Vaccine to Protect Against Future Ebola Outbreaks
[Cameroon Tribune] There are high hopes that any future Ebola outbreak will be tackled easily as the pharmaceutical company, Merck has signed a five million-US Dollars deal with Vaccine Alliance, Gavi in which 300,000 vaccines will be stockpiled ready for emergency use or further clinical trials. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 22, 2016 Category: African Health Source Type: news

Africa: Ebola Vaccine Purchasing Commitment From Gavi to Prepare for Future Outbreaks
[GAVI] Davos -Agreement will help push vaccine towards regulatory approval (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2016 Category: African Health Source Type: news

Ebola Vaccine Just Sold For $5 Million At Davos
DAVOS/LONDON (Reuters) - The Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus. Gavi said the agreement would help the U.S. drugmaker take the experimental Ebola vaccine through late-stage clinical trials to licensing and then through pre-qualification by the World Health Organization (WHO). If approved, Merck's so-called VSV-ZEBOV live attenuated Ebola Zaire vaccine would become one of the world's first licensed Ebola shots and Gavi would be able to sta...
Source: Science - The Huffington Post - January 20, 2016 Category: Science Source Type: news

Ebola: $5m vaccine deal announced
The Vaccine Alliance, Gavi, commits $5m (£3.5m) for buying the Ebola vaccine, to protect against future outbreaks of the deadly virus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 20, 2016 Category: Consumer Health News Source Type: news

Vaccines alliance signs $5 million advance deal for Merck's Ebola shot
DAVOS/LONDON (Reuters) - The Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus. (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Profectus begins Phase I trial of VesiculoVax-vectored vaccine to treat Ebola
Clinical-stage vaccine company Profectus BioSciences has started its Phase I trial of its VesiculoVax-vectored vaccine to treat Ebola. (Source: Drug Development Technology)
Source: Drug Development Technology - January 20, 2016 Category: Pharmaceuticals Source Type: news

WHO responded 'too slowly' to Ebola warnings
UK should lead efforts for WHO shake-upRelated items from OnMedicaUN describes Ebola as ‘threat to peace and security’Britain steps up its involvement in Ebola treatmentUN lacks resources to defeat EbolaExperimental Ebola vaccine effective on needle stick doctor New case reported in Liberia which was declared Ebola free in September (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 19, 2016 Category: UK Health Source Type: news

We Need To Take Action Against Zika Virus Now, U.S. Experts Say
By: Mindy Weisberger Published: 01/15/2016 02:34 AM EST on LiveScience The rapid spread of a disease called Zika virus urgently requires attention, two leading researchers say. Zika virus is the most recent in a list of viruses that were formerly confined to remote niches of the world but are now expanding their reach into the Northern Hemisphere. Much about these viruses is still poorly understood, wrote Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), and Dr. David Morens, senior scientific advisor for the NIAID, in an article published in the New England Journal of M...
Source: Healthy Living - The Huffington Post - January 15, 2016 Category: Consumer Health News Source Type: news

Vladimir Putin claims Russia has created a vaccine for EBOLA
RUSSIAN President Vladimir Putin has announced his country has developed a vaccine for the deadly Ebola virus. (Source: Daily Express - Health)
Source: Daily Express - Health - January 14, 2016 Category: Consumer Health News Source Type: news

Vladimir Putin claims Ebola virus vaccine has been developed by Russia
Russian president announces vaccine for disease that has killed 11,000 in west Africa, but does not go into detail about how it works or any clinical trials Russian President Vladimir Putin has claimed that his country has developed a vaccine for the Ebola virus which has killed thousands of people in west Africa.But Putin, who is famed for his talent for headline-grabbing announcements, did not divulge the vaccine’s name, nor did he say how it worked, who was developing it or give details of any trials. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 14, 2016 Category: Science Authors: Agence-France Presse Tags: Ebola World news Russia Europe Vladimir Putin Health Science Society Source Type: news